The results of FCGR3A polymorphism were established for 120 SA patients (23 in Stage I, 54—Stage II, 23—Stage III, 20—Stage IV of SA), 179 TB patients and 148 healthy individuals. This evidence concerns the gene FCGR3A and tuberculosis.